PSC Biotech, Brand Institute and the Biotechnology Innovation Organization (BIO) have partnered to provide a webinar series on “The Art and Science of Naming Drugs and Medical Devices”. The two-part series will focus on technical and strategic considerations and the legal and regulatory challenges of medical product name development.
On Wednesday, Jan. at 1:00 PM EST you will hear about “The Science Behind Nonproprietary (Generic) Drug Naming” with world-renowned nonproprietary naming expert and the President of Drug Safety Institute’s Nonproprietary Naming Division, Sophia Fuerst. Learn about the taxonomy of nonproprietary nomenclature, the differences between generic and brand naming, and the regulatory agencies/processes involved.
The second part of the series, “The Art of Pharmaceutical and Medical Device Brand Naming,” will launch on Wednesday, Feb. 3 at 1:00 PM EST. Scott Piergrossi and Jerry Phillips will discuss the key challenges and opportunities, creative strategies, and regulatory considerations involved in the development of pharmaceutical and medical device brand names.